The Urgent Need for Biomarkers Beyond B-Type Natriuretic Peptide for the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction

JAMA Cardiol. 2018 Dec 1;3(12):1211. doi: 10.1001/jamacardio.2018.3702.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers
  • Heart Failure*
  • Hospitalization
  • Humans
  • Natriuretic Peptide, Brain*
  • Stroke Volume

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain